Correlation Between Brainstorm Cell and Equitable Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Brainstorm Cell and Equitable Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brainstorm Cell and Equitable Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brainstorm Cell Therapeutics and Equitable Holdings, you can compare the effects of market volatilities on Brainstorm Cell and Equitable Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brainstorm Cell with a short position of Equitable Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brainstorm Cell and Equitable Holdings.

Diversification Opportunities for Brainstorm Cell and Equitable Holdings

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Brainstorm and Equitable is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Brainstorm Cell Therapeutics and Equitable Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equitable Holdings and Brainstorm Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brainstorm Cell Therapeutics are associated (or correlated) with Equitable Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equitable Holdings has no effect on the direction of Brainstorm Cell i.e., Brainstorm Cell and Equitable Holdings go up and down completely randomly.

Pair Corralation between Brainstorm Cell and Equitable Holdings

Assuming the 90 days trading horizon Brainstorm Cell Therapeutics is expected to under-perform the Equitable Holdings. In addition to that, Brainstorm Cell is 4.65 times more volatile than Equitable Holdings. It trades about 0.0 of its total potential returns per unit of risk. Equitable Holdings is currently generating about 0.06 per unit of volatility. If you would invest  2,716  in Equitable Holdings on September 4, 2024 and sell it today you would earn a total of  1,804  from holding Equitable Holdings or generate 66.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.6%
ValuesDaily Returns

Brainstorm Cell Therapeutics  vs.  Equitable Holdings

 Performance 
       Timeline  
Brainstorm Cell Ther 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Brainstorm Cell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Equitable Holdings 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Equitable Holdings are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Equitable Holdings reported solid returns over the last few months and may actually be approaching a breakup point.

Brainstorm Cell and Equitable Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Brainstorm Cell and Equitable Holdings

The main advantage of trading using opposite Brainstorm Cell and Equitable Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brainstorm Cell position performs unexpectedly, Equitable Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equitable Holdings will offset losses from the drop in Equitable Holdings' long position.
The idea behind Brainstorm Cell Therapeutics and Equitable Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA